1.
Microsoft PowerPoint - Garren ECTRIMS 2005 poster.ppt File Format: PDF/Adobe Acrobat - View as HTML Antigen-specific immunomodulation in multiple sclerosis patients treated with MBP encoding DNA plasmid (BHT-3009) alone or combined with atorvastatin ...
2.
BAYHILL THERAPEUTICS - Abstracts DNA Vaccines Forum 2008. March 10 – 11th, 2008. London, UK Studying the Effects of Using an Antigen Specific DNA Plasmid to Treat Multiple Sclerosis ...
3.
BAYHILL THERAPEUTICS March 17, 2009 Bio-Europe Spring 2009 Milan, Italy Bayhill Therapeutics, Partnering Forum Presentation Mark W. Schwartz, Ph.D., CEO & President ...
4.
BAYHILL THERAPEUTICS March 17, 2009 Bio-Europe Spring 2009 Milan, Italy Bayhill Therapeutics, Partnering Forum Presentation Mark W. Schwartz, Ph.D., CEO & President ...
5.
BAYHILL THERAPEUTICS - Overview Bayhill Therapeutics is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA™ platform ...
6.
BAYHILL THERAPEUTICS March 17, 2009 Bio-Europe Spring 2009 Milan, Italy Bayhill Therapeutics, Partnering Forum Presentation Mark W. Schwartz, Ph.D., CEO & President ...
7.
BAYHILL THERAPEUTICS March 17, 2009 Bio-Europe Spring 2009 Milan, Italy Bayhill Therapeutics, Partnering Forum Presentation Mark W. Schwartz, Ph.D., CEO & President ...
8.
BAYHILL THERAPEUTICS - Press Releases May 31, 2006 ... DATE OF EVENT: 30 May, 2006. PLACE: Lausanne, Switzerland. WHO/WHAT/WHERE: Bayhill Therapeutics, a Palo Alto, CA-based biotechnology drug ...
9.
BAYHILL THERAPEUTICS March 17, 2009 Bio-Europe Spring 2009 Milan, Italy Bayhill Therapeutics, Partnering Forum Presentation Mark W. Schwartz, Ph.D., CEO & President ...
10.
BAYHILL THERAPEUTICS March 17, 2009 Bio-Europe Spring 2009 Milan, Italy Bayhill Therapeutics, Partnering Forum Presentation Mark W. Schwartz, Ph.D., CEO & President ...
|
|
View More »
|